| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $105 | +0.0% |
| Cost of Revenue | $464 | +0.0% |
| Gross Profit | -$359 | +0.0% |
| R&D Expense | $24K | +12.2% |
| SG&A Expense | $3.3M | +430.7% |
| Interest Expense | $80K | -28.0% |
| Pre-tax Income | -$15.9M | -383.2% |
| Net Income | -$15.9M | -383.2% |
| EPS (Basic) | -$1.31 | -125.9% |
| EPS (Diluted) | -$1.31 | -125.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $8.8M | — |
| Current Assets | $12.7M | — |
| Total Assets | $14.8M | +1036.2% |
| Current Liabilities | $7.4M | -24.5% |
| Total Liabilities | $11.4M | +16.4% |
| Stockholders' Equity | $3.4M | +140.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | -1058.9% |
| Investing Cash Flow | -$16.1M | — |
| Financing Cash Flow | $23.0M | +3949.7% |